Flutiform

Flutiform is a combination inhaler containing Fluticasone Propionate and Formoterol Fumarate Dihydrate, used for managing asthma and chronic obstructive pulmonary disease (COPD). This medication helps control symptoms and improve breathing.

Flutiform is primarily used for the maintenance treatment of asthma and COPD. It combines an inhaled corticosteroid (Fluticasone Propionate) to reduce inflammation and a long-acting beta-agonist (Formoterol Fumarate Dihydrate) to relax the muscles in the airways. This dual-action approach helps manage symptoms such as wheezing, shortness of breath, and coughing. Flutiform is not intended for immediate relief of acute asthma attacks.

Common effects of Flutiform may include throat irritation, hoarseness, and a dry mouth. Some users might experience tremors, headaches, or an increased heart rate. These effects are generally mild and temporary. If any severe or persistent effects occur, it is important to consult a healthcare professional.

Flutiform should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Patients with certain medical conditions, such as heart disease or diabetes, should use Flutiform with caution. Regular monitoring may be required to ensure the medication is working effectively and safely.

Flutiform may interact with other medications, including beta-blockers, which can reduce its effectiveness. It is also important to avoid using Flutiform with other long-acting beta-agonists to prevent potential side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.